Analytics

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

The multispecific analysis of biologics is a complex task that requires appropriate strategies.

Multispecific Analyses of Biologics Pose Multiple Challenges

Thomas A. Little is president, Thomas A. Little Consulting and BioAssay Sciences, 12401 North Wildflower Lane, Highland, Utah 84003, USA, drlittle@dr-tom.com.

Daniel S. Harding is a principle consultant of Bioassay Sciences.

Ensuring reliable analytical methods and bioassays requires a well-thought-out strategy for evaluating method validity and systems suitability.

Establishing Systems Suitability and Validity Criteria for Analytical Methods and Bioassays

The acquisition of Protein Metrics expands Insightful Science’s R&D solutions to include proteomics.

Insightful Science Completes Acquisition of Protein Metrics

Feliza Mirasol is the science editor for 

Sample preparation tends to be manually labor intensive, but automating this step helps streamline the glycosylation monitoring workflow.

Automation Helps Streamline Glycosylation Monitoring Workflow

Hari Narayanan, PhD, is product marketing manager at Thermo Fisher Scientific.

Persistent bottlenecks in biocatalyst development can be alleviated through fully automated enzyme analysis.

Advancing Enzyme Analysis Through Automation

Genezen has opened its new process development and analytical lab for viral vector production.

Genezen Starts Up Operations at Lenti- and Retroviral Vector Process Development Lab

Bionique Testing Laboratories has been acquired by Asahi Kasei Medical and will join the company’s biosafety testing services unit.

Asahi Kasei Medical Acquires Bionique

The companies will focus on the rapid development of polymerase chain reaction assays for emerging pathogens and potential health threats, including biological threats.

Roche Expands PCR-Test Portfolio with Completion of Purchase Agreement of TIB Molbiol

David Smith is CMO manager at Glide Pharmaceutical Technologies Ltd.

Courtney LeBlon, PhD, Director of Technical Operations, Ori Biotech.

Stephen Shapka, PhD, Lead Automation Engineer, Ori Biotech.

Analytical methods need a boost to ensure quality control for cell and gene therapies.

Contamination Control for Cell and Gene Therapies Needs New Analytics

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.

Analytical Method Development